PTC Therapeutics wants to assure patients and health care providers that the supply of EMFLAZA will not be affected by the coronavirus (COVID-19) pandemic. Currently, over a year’s supply of EMFLAZA is in stock and available for delivery.
Furthermore, we are closely monitoring shipping issues in the United States and will update our patients and health care providers should challenges arise.
Our first priority is providing safe treatment. We know how important access to our therapies is, which is why we are continually looking for the best ways to serve our patients and their caregivers.
For over 20 years, PTC Therapeutics has been dedicated to improving the lives of patients with rare, difficult-to-treat, genetic diseases by providing innovative therapies. We are determined to deliver on that commitment.
If you have any questions or concerns, please call PTC Cares™